ASCL1 and small cell lung carcinoma: Recently, it was shown that SCLC lacking ASCL1, NEUROD1, and POU2F3 (some ∼18%) is enriched for inflammation and immune response genes and shows improved immune checkpoint blockade response (Gay et al., 2021).